Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Chronic Diseases and Translational Medicine|April 18, 2019
Current advances in Hodgkin's lymphomaJoseph Vadakara, Benjamin AndrickTransplantation and Cellular Therapy|February 21, 2022
The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework AnalysisBenjamin Andrick, Lorraine Tusing, Laney K Jones, et al.Pharmacogenomics and Personalized Medicine|December 11, 2012
Personalized medicine and treatment approaches in non-small-cell lung carcinomaJoseph Vadakara, Hossein BorghaeiSouthern Medical Journal|September 3, 2015
Etiologies and Short-Term Mortality in Patients with Ultraelevated Serum FerritinTimothy Beer, Joseph VadakaraCurrent Hematologic Malignancy Reports|October 16, 2012
Targeting CD30 in anaplastic large cell lymphomaJoseph Vadakara, Barbara ProJournal of the Advanced Practitioner in Oncology|February 5, 2021
Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid LeukemiaDennis Marjoncu, Benjamin AndrickCureus|May 1, 2023
Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the SpleenKathie Wu, Joseph VadakaraHematology/Oncology Clinics of North America|October 8, 2013
Gastrointestinal stromal tumors: management of metastatic disease and emerging therapiesJoseph Vadakara, Margaret von MehrenJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 14, 2022
Smaller but more frequent dosing of cefepime in the treatment of febrile neutropeniaLindsay Okubo, Benjamin Andrick, Ricky Rampulla, et al.Clinical Lymphoma, Myeloma & Leukemia|October 3, 2022
Oral Antineoplastics in Acute Myeloid Leukemia: A Comprehensive ReviewArpita Gandhi, Benjamin Andrick, Julianne Darling, et al.Pageof 2